Overview / Abstract: |
Target Audience Program Overview Learning Objectives EXPLAIN the rationale for incorporating newer effective and well-tolerated agents into the frontline treatment of patients with MM |
Expiration |
Jan 14, 2023 |
Discipline(s) |
Physician CME |
Format |
Online |
Credits / Hours |
0.5 |
Accreditation |
ACCME, ANCC |
Presenters / Authors / Faculty |
Faith E. Davies, MBBCh, MRCP, MD, FRCPath |
Sponsors / Supporters / Grant Providers |
Sanofi Genzyme |
Keywords / Search Terms |
Relias LLC Relias, Free CME, Multiple myeloma, MM Free CE CME |